Sussman Norman
Insider CIK 1358508 · DRRX Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| DRRX DURECT CORP | D To issuer deriv | 2025-09-11 | 2025-09-12 | 10,000 | — | $0 | 0 | SEC↗ |
| DRRX DURECT CORP | D To issuer deriv | 2025-09-11 | 2025-09-12 | 20,000 | — | $0 | 0 | SEC↗ |
| DRRX DURECT CORP | D To issuer deriv | 2025-09-11 | 2025-09-12 | 39,837 | — | $0 | 0 | SEC↗ |
| DRRX DURECT CORP | D To issuer deriv | 2025-09-11 | 2025-09-12 | 69,557 | — | $0 | 0 | SEC↗ |
| DRRX DURECT CORP | D To issuer deriv | 2025-09-11 | 2025-09-12 | 104,000 | — | $0 | 0 | SEC↗ |
| DRRX DURECT CORP | D To issuer | 2025-09-11 | 2025-09-12 | 46,425 | — | $0 | 0 | SEC↗ |
| DRRX DURECT CORP | A Award | 2025-07-11 | 2025-07-15 | 46,425 | — | $0 | 46,425 | SEC↗ |
| DRRX DURECT CORP | A Award deriv | 2024-10-14 | 2024-10-16 | 104,000 | — | $0 | 104,000 | SEC↗ |
| DRRX DURECT CORP | A Award deriv | 2023-02-21 | 2023-02-23 | 24,557 | — | $0 | 24,557 | SEC↗ |
| DRRX DURECT CORP | A Award deriv | 2023-02-21 | 2023-02-23 | 45,000 | — | $0 | 45,000 | SEC↗ |
| DRRX DURECT CORP | A Award deriv | 2022-01-06 | 2022-01-10 | 398,380 | — | $0 | 398,380 | SEC↗ |
| DRRX DURECT CORP | S Sale | 2021-12-10 | 2024-09-11 | 9,000 | $1.06 | $9.5K | 0 | SEC↗ |
| DRRX DURECT CORP | A Award deriv | 2021-01-15 | 2021-01-19 | 100,000 | — | $0 | 100,000 | SEC↗ |
| DRRX DURECT CORP | A Award deriv | 2020-11-02 | 2020-11-04 | 200,000 | — | $0 | 200,000 | SEC↗ |